K. M. Konovalov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
K. M. Konovalov has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andrey A. Baranov
Yaroslavl State Medical University
3 shared publications - Natalia A. Lapkina
Yaroslavl State Medical University
2 shared publications E.A. Malygina
1 shared publication- E.V. Rechkina1 shared publication
- Inessa Vorontsova
Yaroslavl State Medical University
1 shared publication - N.I. Korshunov1 shared publication
Latest Publications
- Open Access
- 25 March 2025
- Published by Publishing House OKI in Patient-Oriented Medicine and Pharmacy
- Vol. 3 (1) , 49-58
Clinical indices and laboratory markers for evaluating the immune-mediated inflammation in rheumatoid arthritis: the impact of COVID-19
Rheumatoid arthritis (RA) is an immune-mediated inflammatory disease of unknown etiology that represents a considerable burden for both the patient and the healthcare system. The degree to which inflammation is being controlled determines the prognosis; therefore, achieving remission or low disease activity is of paramount importance to medical practitioners. The effectiveness of the currently employed treatment regimen for a specific patient is determined by the disease activity indices and the change in their values during treatment. The commonly used RA disease activity indices are the result of a painstaking search for the optimal set of clinical, laboratory and instrumental parameters reflecting the underlying pathogenesis of inflammation in RA spanning half a century. Routine laboratory tests not included in these indices can nevertheless provide additional valuable information regarding the disease. The new coronavirus infection, COVID-19, has similar pathogenetic mechanisms with immunoinflammatory rheumatic diseases, and its clinical and laboratory consequences in the form of postcovid-19 syndrome, make it difficult to assess the activity of RA using existing activity indices, raise the question of the need to take them into account when assessing the effectiveness and choosing the tactics of treatment of a patient with RA.
- 25 March 2025
- Published by Publishing House OKI in Patient-Oriented Medicine and Pharmacy
- Vol. 3 (1) , 49-58
Open AccessClinical indices and laboratory markers for evaluating the immune-mediated inflammation in rheumatoid arthritis: the impact of COVID-19
Rheumatoid arthritis (RA) is an immune-mediated inflammatory disease of unknown etiology that represents a considerable burden for both the patient and the healthcare system. The degree to which inflammation is being controlled determines the prognosis; therefore, achieving remission or low disease activity is of paramount importance to medical practitioners. The effectiveness of the currently employed treatment regimen for a specific patient is determined by the disease activity indices and the change in their values during treatment. The commonly used RA disease activity indices are the result of a painstaking search for the optimal set of clinical, laboratory and instrumental parameters reflecting the underlying pathogenesis of inflammation in RA spanning half a century. Routine laboratory tests not included in these indices can nevertheless provide additional valuable information regarding the disease. The new coronavirus infection, COVID-19, has similar pathogenetic mechanisms with immunoinflammatory rheumatic diseases, and its clinical and laboratory consequences in the form of postcovid-19 syndrome, make it difficult to assess the activity of RA using existing activity indices, raise the question of the need to take them into account when assessing the effectiveness and choosing the tactics of treatment of a patient with RA.
- 12 December 2024
- Published by Alfmed LLC in Medical alphabet
- No. 29,p. 68-74
The main pro- and antiinflammatory cytokines in rheumatoid arthritis: interrelationships and pathogenetic significance
Imbalance in the production of pro- and anti-inflammatory cytokines plays an important role in the pathogenesis of rheumatoid arthritis (RA). The aim of the study. To determine the concentration and frequency of increase in serum of pro- and anti-inflammatory cytokines in patients with RA in the advanced stage of the disease, assessment of the relationship between them, clinical and laboratory activity of the disease and autoantibodies. Materials and methods. We examined 154 RA patients (41 men and 113) women, of average age (56.0 [50.0; 64.0] years), disease duration (9.4 [3.0; 13.0] years), seropositive 129 (83.8 %) for IgM rheumatoid factor (RF) and/or 106 (68.8 %) antibodies to cyclic citrullinated peptides (ACCP) with moderate to high (DAS 28-ESR – 5.40 [4.65; 6.00]) disease activity. The concentration of interleukin (IL), tumor necrosis factor α (TNF-α), interferon-γ (INF-γ), soluble CD 40 ligand (sCD 40L) in serum was determined by multiplex technology. Results. In RA patients, the concentration of IL-6, IL-23, IL-31, IL-33 and INF-γ was significantly higher, and TNF-α values were significantly lower than in controls. The levels of IL-1β, IL-17A, IL-17F, IL-25 and sCD 40L were not different from donors. IL-10 values were significantly higher than donors, and IL-4 values were not different from controls. In RA, the frequency of IL-33 elevation was 87.0 %, IL-6 51.6 %, IL-31 48.1 %, IL-17F 46.1 %, IL-23 42.9 % and INF-γ 39.0 %, IL-17A 29.9 %, IL-1β 26.6 %, TNF-α 23.4 %, IL-25 11.7 % and sCD 40L 3.2 % of patients. IL-33 hyperproduction was significantly predominant over other cytokines (p < 0.001). Elevated values of IL-10 were found in 16.2 % and IL-4 in 12.3 % of patients. Hyperproduction of proinflammatory cytokines, except IL-25 and sCD 40L, significantly prevailed over IL-4 and IL-10. Correlations of proinflammatory cytokines among themselves and with IL-4 and IL-10 were found. High values of IL-33 were associated only with IL-31. IL-4 and IL-10 concentrations were significantly correlated with each other. IL-6 concentration was found to be associated with DAS 28-ESR, CDAI and SDAI; IL-25 and sCD 40L were associated with CDAI and SDAI; IL-17A and IL-33 were associated with SDAI; IL-4 and IL-10, with CDAI and SDAI; IL-31 and IL-33, with CRP; TNF-α and INF-γ, with CRP; IL-17A, and IgM RF and ACCP; IL-31 and INF-γ, with IgM RF. IL-4 and IL10 were positively correlated with IgM RF, and IL-4 was negatively correlated with ADCP. Conclusions. In RA patients in the advanced stage of the disease, there is an imbalance between pro- and anti-inflammatory cytokines, with a predominance of IL-33 production. Despite the presence of interrelationships between cytokines, there are significant differences between them in associations with clinical indices, laboratory indicators of disease activity and autoantibodies.
- 12 December 2024
- Published by Alfmed LLC in Medical alphabet
- No. 29,p. 68-74
The main pro- and antiinflammatory cytokines in rheumatoid arthritis: interrelationships and pathogenetic significance
Imbalance in the production of pro- and anti-inflammatory cytokines plays an important role in the pathogenesis of rheumatoid arthritis (RA). The aim of the study. To determine the concentration and frequency of increase in serum of pro- and anti-inflammatory cytokines in patients with RA in the advanced stage of the disease, assessment of the relationship between them, clinical and laboratory activity of the disease and autoantibodies. Materials and methods. We examined 154 RA patients (41 men and 113) women, of average age (56.0 [50.0; 64.0] years), disease duration (9.4 [3.0; 13.0] years), seropositive 129 (83.8 %) for IgM rheumatoid factor (RF) and/or 106 (68.8 %) antibodies to cyclic citrullinated peptides (ACCP) with moderate to high (DAS 28-ESR – 5.40 [4.65; 6.00]) disease activity. The concentration of interleukin (IL), tumor necrosis factor α (TNF-α), interferon-γ (INF-γ), soluble CD 40 ligand (sCD 40L) in serum was determined by multiplex technology. Results. In RA patients, the concentration of IL-6, IL-23, IL-31, IL-33 and INF-γ was significantly higher, and TNF-α values were significantly lower than in controls. The levels of IL-1β, IL-17A, IL-17F, IL-25 and sCD 40L were not different from donors. IL-10 values were significantly higher than donors, and IL-4 values were not different from controls. In RA, the frequency of IL-33 elevation was 87.0 %, IL-6 51.6 %, IL-31 48.1 %, IL-17F 46.1 %, IL-23 42.9 % and INF-γ 39.0 %, IL-17A 29.9 %, IL-1β 26.6 %, TNF-α 23.4 %, IL-25 11.7 % and sCD 40L 3.2 % of patients. IL-33 hyperproduction was significantly predominant over other cytokines (p < 0.001). Elevated values of IL-10 were found in 16.2 % and IL-4 in 12.3 % of patients. Hyperproduction of proinflammatory cytokines, except IL-25 and sCD 40L, significantly prevailed over IL-4 and IL-10. Correlations of proinflammatory cytokines among themselves and with IL-4 and IL-10 were found. High values of IL-33 were associated only with IL-31. IL-4 and IL-10 concentrations were significantly correlated with each other. IL-6 concentration was found to be associated with DAS 28-ESR, CDAI and SDAI; IL-25 and sCD 40L were associated with CDAI and SDAI; IL-17A and IL-33 were associated with SDAI; IL-4 and IL-10, with CDAI and SDAI; IL-31 and IL-33, with CRP; TNF-α and INF-γ, with CRP; IL-17A, and IgM RF and ACCP; IL-31 and INF-γ, with IgM RF. IL-4 and IL10 were positively correlated with IgM RF, and IL-4 was negatively correlated with ADCP. Conclusions. In RA patients in the advanced stage of the disease, there is an imbalance between pro- and anti-inflammatory cytokines, with a predominance of IL-33 production. Despite the presence of interrelationships between cytokines, there are significant differences between them in associations with clinical indices, laboratory indicators of disease activity and autoantibodies.
- 15 March 2024
- Published by Postgraduate Institute for Public Health Worker under Health Ministry of Khabarovsk Krai in Public health of the Far East Peer-reviewed scientific and practical journal
- Vol. 1 (99)
New coronavirus infection (COVID-19) and the nosological structure of patients of the rheumatological department. A glance look from the region
- 15 March 2024
- Published by Postgraduate Institute for Public Health Worker under Health Ministry of Khabarovsk Krai in Public health of the Far East Peer-reviewed scientific and practical journal
- Vol. 1 (99)
New coronavirus infection (COVID-19) and the nosological structure of patients of the rheumatological department. A glance look from the region